Cellular retinoic acid binding protein is associated with mitochondria

Prior research has shown that cellular retinoic acid-binding proteins (CRABPs) are typically cytoplasmic in many cell types. It was already known that CRABPs differ from CRBPs in their ligand specificity and tissue distribution. No prior work had resolved whether CRABP could associate with organelles beyond the cytoplasm. This gap motivated investigations into CRABP localization in specific tissues like the adrenal cortex. CRBP was understood to be more broadly distributed within cells, but its organelle interactions remained unclear. That uncertainty drove experiments using fluorescent markers to map CRABP's subcellular location. The adrenal cortex was chosen due to its known roles in steroidogenesis and retinoid signaling. This study aimed to clarify CRABP's localization and compare it to CRBP in the same cellular context.

The aim was to determine the subcellular localization of CRABP in bovine adrenal cortex cells. Researchers sought to compare CRABP's distribution with CRBP using immunohistochemistry and transfection models. They hypothesized that CRABP might associate with mitochondria, given its cytoplasmic punctate pattern. The study also aimed to confirm this hypothesis using organelle-specific fluorochromes. Subcellular fractionation was planned to isolate mitochondria and test for CRABP co-sedimentation. CRBP was used as a control to distinguish CRABP-specific findings from general lipid-binding protein behavior. This work sought to clarify CRABP's novel organelle association within the lipid-binding protein superfamily. The results could refine understanding of CRABP's functional roles in cellular retinoid metabolism.

Immunohistochemistry was performed on bovine adrenal cortex tissue to detect CRABP and CRBP. Cultured cells were transfected with CRABP and CRBP constructs to observe expression patterns. Immunofluorescence microscopy was used to visualize CRABP and CRBP localization in transfected cells. Fluorochromes specific to mitochondria were applied to compare with CRABP fluorescence patterns. Subcellular fractionation of adrenal cortex tissue was conducted to isolate mitochondria. CRABP and CRBP were analyzed for co-sedimentation with mitochondrial fractions. Immunoblotting confirmed the presence of CRABP in mitochondrial fractions. This multi-step approach combined imaging and biochemical techniques to map CRABP localization.

CRABP staining was cytoplasmic and punctate in bovine adrenal cortex cells. CRBP staining was diffuse and not restricted to specific organelles. Transfected CRABP showed cytoplasmic localization with a punctate pattern. CRBP transfected cells showed no such restriction or punctate appearance. Mitochondrial fluorochrome patterns matched CRABP fluorescence in transfected cells. Subcellular fractionation confirmed CRABP co-sedimented with mitochondria. CRBP did not co-sediment with mitochondrial fractions in the same experiment. This is the first reported association of a lipid-binding protein with mitochondria.

CRABP is localized to mitochondria in bovine adrenal cortex cells. This localization was confirmed using both imaging and biochemical fractionation methods. CRBP remains cytoplasmic and does not associate with mitochondria. The punctate CRABP pattern corresponds to mitochondrial distribution. CRABP co-sedimented with mitochondria in subcellular fractionation experiments. This finding is novel for the lipid-binding protein superfamily. The study suggests CRABP may have a mitochondrial role in retinoid metabolism. Further work is needed to clarify the functional implications of this localization.